Results 211 to 220 of about 1,183,826 (262)
CXCL10 Regulates Pressure Overload-Induced Heart Failure. [PDF]
Souza-Neto F +16 more
europepmc +1 more source
Periodontal Disease and Risk of Heart Failure: A Systematic Review and Meta-Analysis. [PDF]
Valenzuela-Rodríguez G +3 more
europepmc +1 more source
Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure.
Ibrahim R +16 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2005
Although heart failure is common, disabling, and deadly, there are now many effective treatments, at least for patients with low left-ventricular ejection fraction. For all, angiotensin-converting-enzyme inhibitors and beta blockers are the essential disease-modifying treatments, improving symptoms, reducing hospital admissions, and increasing survival.
John J V, McMurray, Marc A, Pfeffer
openaire +3 more sources
Although heart failure is common, disabling, and deadly, there are now many effective treatments, at least for patients with low left-ventricular ejection fraction. For all, angiotensin-converting-enzyme inhibitors and beta blockers are the essential disease-modifying treatments, improving symptoms, reducing hospital admissions, and increasing survival.
John J V, McMurray, Marc A, Pfeffer
openaire +3 more sources
Annals of Internal Medicine, 2018
Heart failure affects more than 6 million people in the United States and incurs a heavy toll in morbidity, mortality, and health care costs. It frequently coexists with other important disorders, including hypertension, coronary artery disease, diabetes, and obesity.
Róisín, Trainor +3 more
openaire +5 more sources
Heart failure affects more than 6 million people in the United States and incurs a heavy toll in morbidity, mortality, and health care costs. It frequently coexists with other important disorders, including hypertension, coronary artery disease, diabetes, and obesity.
Róisín, Trainor +3 more
openaire +5 more sources
The Lancet, 2017
Heart failure is common in adults, accounting for substantial morbidity and mortality worldwide. Its prevalence is increasing because of ageing of the population and improved treatment of acute cardiovascular events, despite the efficacy of many therapies for patients with heart failure with reduced ejection fraction, such as angiotensin converting ...
Metra, Marco, Teerlink, John R
openaire +3 more sources
Heart failure is common in adults, accounting for substantial morbidity and mortality worldwide. Its prevalence is increasing because of ageing of the population and improved treatment of acute cardiovascular events, despite the efficacy of many therapies for patients with heart failure with reduced ejection fraction, such as angiotensin converting ...
Metra, Marco, Teerlink, John R
openaire +3 more sources

